Quantamental Technologies’s Haemonetics HAE Stock Holding History

Quantamental Technologies’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,863	Closed	-$257K	–	333
2021 Q2	$257K	Buy	+3,863	New	+$273K	0.23%	181
2019 Q4	–	Sell	-5,990	Closed	-$756K	–	800
2019 Q3	$756K	Buy	5,990 +3,607	+151%	+$458K	0.25%	73
2019 Q2	$287K	Buy	+2,383	New	+$234K	0.11%	315

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

LCP

LGT Capital Partners Pfaeffikon, Switzerland $1.97B AUM 15.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Quantamental Technologies's HAE Position: Q3 2021 in Review

Quantamental Technologies sold out of Haemonetics (HAE) in Q3 2021, closing a stake of 3,863 shares — an estimated $257K sold.

Quantamental Technologies first reported a position in HAE in Q2 2019 and held it in 3 quarters. The position peaked at $756K in Q3 2019. 245 funds tracked by Wall St. Rank hold HAE as of Q3 2021.

Quantamental Technologies reported no remaining Haemonetics position as of Q3 2021 after selling out during the quarter.
Quantamental Technologies sold 3,863 Haemonetics shares in Q3 2021, an estimated $257K.
Quantamental Technologies first reported a position in Haemonetics in Q2 2019 and held it in 3 quarters.
Quantamental Technologies's Haemonetics position peaked at $756K in Q3 2019.
245 funds tracked by Wall St. Rank held Haemonetics as of Q3 2021.

Based on Quantamental Technologies's 13F filing for Q3 2021, filed 15 Nov 2021.